Establishment Labs Holdings Inc

Establishment Labs Holdings Inc Stock Forecast & Price Prediction

Live Establishment Labs Holdings Inc Stock (ESTA) Price
$39.32

3

Ratings

  • Buy 3
  • Hold 0
  • Sell 0
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$39.32

P/E Ratio

-12.74

Volume Traded Today

$1.2M

Dividend

Dividends not available for ESTA

52 Week High/low

60.12/21.26

Establishment Labs Holdings Inc Market Cap

$1.18B

๐Ÿ›‘ Alert: These ten stocks could have higher potential than $ESTA ๐Ÿ›‘

Before you buy ESTA you'll want to see this list of ten stocks that have huge potential. Want to see if ESTA made the cut? Enter your email below

ESTA Summary

Based on ratings from 3 stock analysts, the Establishment Labs Holdings Inc stock price is expected to increase by 55.98% in 12 months. This is calculated by using the average 12-month stock price forecast for Establishment Labs Holdings Inc. The lowest target is $46 and the highest is $75. Please note analyst price targets are not guaranteed and could be missed completely.

ESTA Analyst Ratings

ESTA is a stock in Healthcare which has been forecasted to be worth $61.33 as an average. On the higher end, the forecast price is $75 USD by Allen Gong from JP Morgan and on the lower end ESTA is forecasted to be $46 by from .

ESTA stock forecast by analyst

These are the latest 20 analyst ratings of ESTA.

Analyst/Firm

Rating

Price Target

Change

Date

Marie Thibault
BTIG

Buy

$65

Maintains

Oct 14, 2024
Joanne Wuensch
Citigroup

Neutral

$50

Maintains

Oct 1, 2024
Joanne Wuensch
Citigroup

Neutral

$45

Maintains

Aug 22, 2024
George Sellers
Stephens & Co.

Overweight

$68

Reiterates

Aug 7, 2024
Allen Gong
JP Morgan

Overweight

$50

Maintains

Aug 7, 2024

Citigroup

Neutral


Maintains

Jul 11, 2024
Joanne Wuensch
Citigroup

Neutral

$50

Maintains

Jul 10, 2024
Anthony Petrone
Mizuho

Buy

$70

Maintains

Jun 6, 2024
Joanne Wuensch
Citigroup

Neutral

$60

Downgrade

May 22, 2024
Joanne Wuensch
Citigroup

Buy

$60

Maintains

Apr 3, 2024
Anthony Petrone
Mizuho

Buy

$65

Reiterates

Apr 1, 2024
Joshua Jennings
TD Cowen

Outperform

$60

Maintains

Mar 12, 2024
Allen Gong
JP Morgan

Overweight

$53

Maintains

Feb 29, 2024
George Sellers
Stephens & Co.

Overweight

$47

Reiterates

Jan 11, 2024
Neil Chatterji
B. Riley Securities

Buy

$50

Maintains

Nov 9, 2023
Anthony Petrone
Mizuho

Buy

$50

Maintains

Nov 8, 2023

TD Cowen

Outperform


Maintains

Nov 8, 2023
Allen Gong
JP Morgan

Overweight

$75

Initiates

Aug 31, 2023

Stephens & Co.

Overweight


Reiterates

Jul 21, 2023
Joanne Wuensch
Citigroup

Buy

$79

Initiates

Jun 29, 2023

ESTA Company Information

What They Do: Manufactures medical devices for aesthetic surgery.

Business Model: The company generates revenue by selling silicone gel-filled breast implants and related medical devices primarily to physicians, hospitals, and clinics through a combination of distributors and a direct sales force. Its flagship products include the Motiva Implants brand, which encompasses various advanced breast implant options.

Other Information: Established in 2004 and headquartered in Alajuela, Costa Rica, the company operates in multiple regions including Europe, the Middle East, Latin America, and Asia, positioning itself within the growing medical aesthetics market.
ESTA
Establishment Labs Holdings Inc (ESTA)

When did it IPO

2018

Staff Count

857

Country

Costa Rica

Sector/Industry

Healthcare/Medical Devices

CEO

Mr. Juan Jose Chacon Quiros

Market Cap

$1.18B

Establishment Labs Holdings Inc (ESTA) Financial Data

In 2023, ESTA generated $165.2M in revenue, which was a increase of 2.13% from the previous year. This can be seen as a signal that ESTA's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

$84.7M

Revenue From 2021

$126.7M

49.61 %
From Previous Year

Revenue From 2022

$161.7M

27.64 %
From Previous Year

Revenue From 2023

$165.2M

2.13 %
From Previous Year
  • Revenue TTM $153.1M
  • Operating Margin TTM -32.7%
  • Gross profit TTM $107.0M
  • Return on assets TTM -12.1%
  • Return on equity TTM -223.5%
  • Profit Margin -46.1%
  • Book Value Per Share 1.16%
  • Market capitalisation $1.18B
  • Revenue for 2021 $126.7M
  • Revenue for 2022 $161.7M
  • Revenue for 2023 $165.2M
  • EPS this year (TTM) $-2.59

Establishment Labs Holdings Inc (ESTA) Latest News

News Image

Mon, 11 Nov 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - Establishment Labs Holdings Inc. (NASDAQ: ESTA) will participate in the 2024 UBS Global Healthcare Conference from November 11-14, featuring CEO Juan Josรฉ Chacรณn-Quirรณs and CFO Raj Denhoy.

Why It Matters - Participation in key investment conferences can enhance visibility and credibility for Establishment Labs, potentially attracting investors and driving stock performance.

News Image

Sat, 09 Nov 2024

Sentiment - NEUTRAL

Source - Seeking Alpha

Summary - Establishment Labs Holdings Inc. (NASDAQ: ESTA) held its Q3 2024 earnings call on November 7, 2024, with key executives discussing company performance and future outlook.

Why It Matters - The earnings call details provide insights into Establishment Labs' financial health and performance, influencing stock valuation and investor sentiment.

News Image

Thu, 07 Nov 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - Establishment Labs Holdings Inc. reported Q3 2024 revenue of $40.2 million and updated its 2024 revenue guidance to $165-$168 million, down from $174-$184 million.

Why It Matters - Establishment Labs' revenue guidance cut indicates potential challenges ahead, which may affect stock performance and investor sentiment regarding future growth prospects.

News Image

Thu, 07 Nov 2024

Sentiment - NEGATIVE

Source - Zacks Investment Research

Summary - Establishment Labs (ESTA) reported a quarterly loss of $0.59 per share, better than the expected loss of $0.61, and an improvement from a loss of $1.12 per share a year prior.

Why It Matters - Establishment Labs' smaller quarterly loss than expected suggests improving financial performance, potentially boosting investor confidence and affecting stock valuation positively.

News Image

Thu, 07 Nov 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - Establishment Labs Holdings Inc. has entered a securities purchase agreement for 765,696 common shares and pre-funded warrants for an additional 328,161 shares in a registered direct offering.

Why It Matters - The securities purchase agreement indicates capital raising efforts, which may impact share dilution and financial stability, influencing investor sentiment and stock performance.

News Image

Thu, 31 Oct 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - Establishment Labs Holdings (NASDAQ: ESTA) presented three-year clinical results for Mia Femtechโ„ข at the World Symposium on Ergonomic Implants in Barcelona, focusing on women's health in breast aesthetics and reconstruction.

Why It Matters - The presentation of positive three-year clinical results for Mia Femtechโ„ข could enhance investor confidence in Establishment Labs' growth potential and market position in women's health.

...

ESTA Frequently asked questions

The highest forecasted price for ESTA is $75 from Allen Gong at JP Morgan.

The lowest forecasted price for ESTA is $46 from from

The ESTA analyst ratings consensus are 3 buy ratings, 0 hold ratings, and 0 sell ratings.